Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 15/20 | 0.38 |
| ▸ | JAK2 | O60674 | 14/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25818250 | 0.90 | NTRK1 (0.39) | NTRK1JAK2BACE1 | |
| SCHEMBL30339061 | 0.86 | NTRK1 (0.39) | NTRK1JAK2 | |
| SCHEMBL25816476 | 0.86 | NTRK1 (0.39) | NTRK1JAK2 | |
| SCHEMBL30339094 | 0.86 | NTRK1 (0.39) | NTRK1JAK2 | |
| SCHEMBL25816482 | 0.86 | NTRK1 (0.39) | NTRK1JAK2 | |
| SCHEMBL25818222 | 0.79 | GPR119 (0.37) | — | |
| SCHEMBL22608901 | 0.79 | NTRK1 (0.40) | NTRK1JAK2 | |
| SCHEMBL30339235 | 0.78 | NTRK1 (0.42) | NTRK1JAK2 | |
| SCHEMBL22608904 | 0.78 | NTRK1 (0.42) | NTRK1JAK2 | |
| SCHEMBL31205609 | 0.78 | NTRK1 (0.42) | NTRK1JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219937-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | SANOFI (FR) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219937-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | RIPK1, RIPK4, RIPK2 | NTRK1 1975/4885JAK2 583/4885BACE1 3605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.